does this statement make sense Synergistically, PTH and calcitriol increase low blood calcium levels by increasing calcium levels in the serum, which act as a negative feedback loop, signalling the parathyroid glands to stop the release of PTH
Question
does this statement make sense Synergistically, PTH and calcitriol increase low blood calcium levels by increasing calcium levels in the serum, which act as a negative feedback loop, signalling the parathyroid glands to stop the release of PTH
Solution
Yes, the statement does make sense. Here's a step-by-step breakdown:
-
"Synergistically, PTH and calcitriol increase low blood calcium levels by increasing calcium levels in the serum": This part of the statement is saying that Parathyroid Hormone (PTH) and calcitriol work together to increase the levels of calcium in the blood when they are low. They do this by increasing the amount of calcium in the serum, the liquid part of the blood.
-
"which act as a negative feedback loop, signalling the parathyroid glands to stop the release of PTH": This part of the statement is explaining the mechanism by which the body maintains calcium homeostasis. When the levels of calcium in the blood increase, this acts as a signal to the parathyroid glands to stop releasing PTH, thus preventing the levels of calcium in the blood from becoming too high. This is an example of a negative feedback loop, a common mechanism in the body for maintaining homeostasis.
Similar Questions
An increased blood calcium level stimulates the release of:Multiple choice question.calcitriolcalcitoninparathyroid hormone (PTH)
Parathyroid hormone will increase blood calcium levels. True False
Parathyroid hormone (PTH) serves a key role in calcium homeostasis. The main function of PTH is to increase plasma calcium concentration. PTH secretion is closely regulated by changes in plasma calcium concentration, which are detected by the human calcium-sensing receptor (hCaSR), a G protein–coupled receptor located on chief cells of the parathyroid gland. hCaSR activation ultimately inhibits PTH release by inducing a second messenger cascade in which intracellular calcium levels rise due to the hydrolysis of the membrane phospholipid phosphatidylinositol bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG) by the membrane-bound enzyme phospholipase C (PLC).Secondary hyperparathyroidism (SHPT) is a condition characterized by excessive PTH release in response to depressed serum calcium or elevated serum phosphate levels. The novel peptide AMG 416, an hCaSR agonist, is being investigated as a possible treatment for SHPT caused by end-stage renal disease (ESRD). IP-1, a metabolite that acts downstream of IP3, is a marker of hCaSR activity. Researchers used embryonic kidney cells lacking hCaSR (HEK-293T) and HEK-293T clone cells stably transfected with hCaSR (hCaSR) to measure IP-1 levels following AMG 416 treatment (Figure 1).Figure 1 IP-1 concentration in embryonic kidney cells lacking hCaSR (HEK-293T) and HEK-293T clone cells transfected with hCaSR (hCaSR) following AMG 416 treatmentThe dependence of AMG 416 on extracellular calcium was investigated by incubating hCaSR cells with increasing concentrations of AMG 416 in the presence or absence of calcium (Figure 2).Figure 2 IP-1 levels in hCaSR cells incubated with and without calcium and AMG 416 peptide (Note: IP-1 levels are normalized to the number of cells present in each culture.)In addition, the effect of AMG 416 on PTH concentration was measured in wild-type (WT) rats. Blood samples were taken from male and female rats for 8 hours following administration of varying concentrations of AMG 416 (Figure 3), and PTH levels were measured.Figure 3 Serum PTH concentration following administration of AMG 416 to WT ratsAMG 416 (Velcalcetide) Activates the Calcium Sensing Receptor. Sarah Walter, Amos Baruch, Jin Dong, et al. Journal of Pharmacology and Experimental Therapeutics August 1, 2013, 346 (2) 229-240 Question 39Which of the following is a potential complication of secondary hyperparathyroidism?A.Decreased bone mineralizationB.Decreased osteoclast activityC.Increased osteoblast activityD.Increased cortical bone massSubmit
The opposing roles of the thyroid and parathyroid hormones maintain the balance of calcium and phosphate ions in the blood. What will happen if the parathyroid gland develops a defect that prevents PTH secretion?Multiple ChoiceThe amount of calcium ions in the blood will increase and the amount of phosphate ions will decrease.The amount of calcium ions and phosphate ions in the blood will increase.The amount of calcium ions and phosphate ions in the blood will decrease.The amount of calcium ions in the blood will decrease and the amount of phosphate ions will increase.
Effector: Synergistically, PTH and calcitriol (vitamin D) increase low blood calcium levels. Osteoclast activity is stimulated by PTH, which promotes bone release and resorption of calcium into the blood (Khan et al., 2022). Furthermore, PTH stimulates the kidneys to convert vitamin D from inactive to active form, calcitriol. This will encourage calcium absorption in the small intestine, increasing blood calcium levels. Together, these mechanisms elevate calcium levels in the blood and restore calcium homeostasis. Increased calcium levels in the serum act as a negative feedback loop, signalling the parathyroid glands to stop the release of PTH is this statement correct?
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.